Streetbeat News

Analyst Ratings

CLDX

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Celldex Therapeutics (NASDAQ:CLDX) and maintained a price target of $73.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:51 am

IPSC

EF Hutton analyst Tony Butler has reiterated a 'Buy' rating on Century Therapeutics (NASDAQ:IPSC) and maintained a price target of $16.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:50 am

AFCG

EF Hutton analyst Gaurav Mehta has reiterated a 'Buy' rating on AFC Gamma (NASDAQ:AFCG) and maintained a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:49 am

TERN

HC Wainwright & Co. analyst Ed Arce maintains a Neutral rating on Terns Pharma (NASDAQ:TERN) and lowers the price target from $11 to $8.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:48 am

ADAP

EF Hutton analyst Tony Butler has reiterated a 'Buy' rating on Adaptimmune Therapeutics (NASDAQ:ADAP) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:47 am

MGY

Keybanc analyst Tim Rezvan has downgraded Magnolia Oil & Gas (NYSE:MGY) from Overweight to Sector Weight.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:46 am

GPOR

Keybanc analyst Tim Rezvan has upgraded Gulfport Energy (NYSE:GPOR) from Sector Weight to Overweight and announced a price target of $145.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:45 am

VRCA

Needham analyst Serge Belanger has reiterated a 'Buy' rating on Verrica Pharmaceuticals (NASDAQ:VRCA) and maintained a price target of $10.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:44 am

APEI

Barrington Research analyst Alexander Paris has reiterated an 'Outperform' rating on American Public Education (NASDAQ:APEI) and maintained a price target of $8.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:43 am

TWOU

Barrington Research analyst Alexander Paris has reiterated an 'Outperform' rating on 2U (NASDAQ:TWOU) and maintained a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 8:43 am